Phase II study of OSI-774 in patients with metastatic colorectal cancer

被引：0
|
作者：
Townsley, C
Major, P
Siu, LL
Dancey, J
Vincent, M
Pond, G
MacLean, M
Moore, MJ
Oza, AM
机构：
[1] Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M4X 1K9, Canada
[2] Hamilton Reg Canc Ctr, Dept Med Oncol, Hamilton, ON L8V 1C3, Canada
[3] Natl Canc Inst, Div Canc Treatment Diagnosis Ctr, Rockville, MD USA
[4] London Reg Canc Ctr, Dept Med Oncol, London, England
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
179
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [41] Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
    Li, Wenhua
    Xu, Jianming
    Shen, Lin
    Liu, Tianshu
    Guo, Weijian
    Zhang, Wen
    Chen, Zhiyu
    Zhu, Xiaodong
    Li, Jin
    BMC CANCER, 2014, 14
  • [42] Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
    Wenhua Li
    Jianming Xu
    Lin Shen
    Tianshu Liu
    Weijian Guo
    Wen Zhang
    Zhiyu Chen
    Xiaodong Zhu
    Jin Li
    BMC Cancer, 14
  • [43] A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancer
    Goel, S
    Wadler, S
    Hoffman, A
    Volterra, F
    Baker, C
    Nazario, E
    Ivy, P
    Silverman, A
    Mani, S
    INVESTIGATIONAL NEW DRUGS, 2003, 21 (01) : 103 - 107
  • [44] Phase II Study of Therapeutic Vaccine Shows Efficacy in Patients with Metastatic Colorectal Cancer
    不详
    PRACTICAL GASTROENTEROLOGY, 2007, 31 (10) : 86 - 89
  • [45] Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer
    Meadows, SM
    Mulkerin, D
    Berlin, J
    Bailey, H
    Kolesar, J
    Warren, D
    Thomas, JP
    JOURNAL OF GASTROINTESTINAL CANCER, 2002, 32 (2-3) : 125 - 128
  • [46] Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer
    Sherry Morgan Meadows
    Daniel Mulkerin
    Jordan Berlin
    Howard Bailey
    Jill Kolesar
    Deb Warren
    James P. Thomas
    International Journal of Gastrointestinal Cancer, 2002, 32 : 125 - 128
  • [47] TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer
    Herbst, RS
    Prager, D
    Hermann, R
    Fehrenbacher, L
    Johnson, BE
    Sandler, A
    Kris, MG
    Tran, HT
    Klein, P
    Li, X
    Ramies, D
    Johnson, DH
    Miller, VA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 5892 - 5899
  • [48] Phase II Clinical and Pharmacokinetic Study of Aflibercept in Patients with Previously Treated Metastatic Colorectal Cancer
    Tang, Patricia A.
    Cohen, Steven J.
    Kollmannsberger, Christian
    Bjarnason, Georg
    Virik, Kiran
    MacKenzie, Mary J.
    Lourenco, Lillian
    Wang, Lisa
    Chen, Alice
    Moore, Malcolm J.
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 6023 - 6031
  • [49] A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer
    Renouf, Daniel J.
    Welch, Stephen
    Moore, Malcolm J.
    Krzyzanowska, Monika K.
    Knox, Jennifer
    Feld, Ronald
    Liu, Geoffrey
    MacKay, Helen
    Petronis, Jennifer
    Wang, Lisa
    Chen, Eric
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1339 - 1344
  • [50] Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer
    Koizumi, W.
    Boku, N.
    Yamaguchi, K.
    Miyata, Y.
    Sawaki, A.
    Kato, T.
    Toh, Y.
    Hyodo, I.
    Nishina, T.
    Furuhata, T.
    Miyashita, K.
    Okada, Y.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 766 - 771
12345